These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 2994424
1. Longitudinal assessment of persistent generalized lymphadenopathy (PGL) in homosexual men. Mathur-Wagh U, Mildvan D, Spigland I, Brun-Vezinet F, Barre-Sinoussi F, Montagnier L, Chermann JC. Adv Exp Med Biol; 1985; 187():93-6. PubMed ID: 2994424 [No Abstract] [Full Text] [Related]
2. Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome. Brun-Vezinet F, Rouzioux C, Barre-Sinoussi F, Klatzmann D, Saimot AG, Rozenbaum W, Christol D, Gluckmann JC, Montagnier L, Chermann JC. Lancet; 1984 Jun 09; 1(8389):1253-6. PubMed ID: 6144973 [Abstract] [Full Text] [Related]
3. The syndrome of persistent generalized lymphadenopathy: experience with 101 patients. Gottlieb MS, Wolfe PR, Fahey JL, Knight S, Hardy D, Eppolito L, Ashida E, Patel A, Beall GN, Sun N. Adv Exp Med Biol; 1985 Jun 09; 187():85-91. PubMed ID: 2994423 [No Abstract] [Full Text] [Related]
4. Acquired immune dysfunction in homosexual men: immunologic profiles. Ammann AJ, Abrams D, Conant M, Chudwin D, Cowan M, Volberding P, Lewis B, Casavant C. Clin Immunol Immunopathol; 1983 Jun 09; 27(3):315-25. PubMed ID: 6223758 [Abstract] [Full Text] [Related]
5. Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state. Laurence J, Brun-Vezinet F, Schutzer SE, Rouzioux C, Klatzmann D, Barré-Sinoussi F, Chermann JC, Montagnier L. N Engl J Med; 1984 Nov 15; 311(20):1269-73. PubMed ID: 6092953 [Abstract] [Full Text] [Related]
6. IgG-antibodies to HTLV-III in patients with AIDS, LAS, and persons at risk of AIDS in West Germany. Hehlmann R, Kreeb G, Erfle V, Piechowiak H, Krüger G, Goebel FD. Blut; 1985 Jan 15; 50(1):13-8. PubMed ID: 2981593 [Abstract] [Full Text] [Related]
8. Relation of HTLV-III seropositivity and lymphadenopathy. Jeffries E, Boyko WJ, Willoughby B, Constance PD, Wiggs B, O'Shaughnessy M, Sharp FR. Can Med Assoc J; 1985 Jul 15; 133(2):111-2. PubMed ID: 2988732 [Abstract] [Full Text] [Related]
9. Immunological studies of homosexual men with immunodeficiency and Kaposi's sarcoma. Schroff RW, Gottlieb MS, Prince HE, Chai LL, Fahey JL. Clin Immunol Immunopathol; 1983 Jun 15; 27(3):300-14. PubMed ID: 6603314 [Abstract] [Full Text] [Related]
10. Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston. Groopman JE, Mayer KH, Sarngadharan MG, Ayotte D, Devico AL, Finberg R, Sliski AH, Allan JD, Gallo RC. Ann Intern Med; 1985 Mar 15; 102(3):334-7. PubMed ID: 2982305 [Abstract] [Full Text] [Related]
11. Early warning skin signs in AIDS and persistent generalized lymphadenopathy. Muhlemann MF, Anderson MG, Paradinas FJ, Key PR, Dawson SG, Evans BA, Murray-Lyon IM, Cream JJ. Br J Dermatol; 1986 Apr 15; 114(4):419-24. PubMed ID: 3008802 [Abstract] [Full Text] [Related]
12. The Vancouver Lymphadenopathy-AIDS Study: 3. Relation of HTLV-III seropositivity, immune status and lymphadenopathy. Boyko WJ, Schechter MT, Jeffries E, Douglas B, Maynard M, O'Shaughnessy M. Can Med Assoc J; 1985 Jul 01; 133(1):28-32. PubMed ID: 2988730 [Abstract] [Full Text] [Related]
13. Antibodies to HTLV-III in patients with acquired immunodeficiency or lymphadenopathy syndrome in West Germany. Hehlmann R, Kreeb G, Erfle V, Piechowiak H, Krüger G, Goebel FD. Lancet; 1984 Nov 10; 2(8411):1094. PubMed ID: 6150160 [No Abstract] [Full Text] [Related]
14. Persistent lymphadenopathy in homosexual men: a clinical and ultrastructural study. Anderson MG, Dixey J, Key P, Ellis DS, Tovey G, McCaul TF, Murray-Lyon IM, Gazzard B, Lawrence A, Evans B. Lancet; 1984 Apr 21; 1(8382):880-2. PubMed ID: 6143189 [Abstract] [Full Text] [Related]
15. Spectrum of Kaposi's sarcoma in the epidemic of AIDS. Safai B, Sarngadharan MG, Koziner B, Godbold J, Myskowski PL, Cunningham-Rundles S, Johnson K, Gold J, Krown S, Dupont B. Cancer Res; 1985 Sep 21; 45(9 Suppl):4646s-4648s. PubMed ID: 2990700 [Abstract] [Full Text] [Related]
16. Virus-neutralizing activity, serologic heterogeneity, and retrovirus isolation from homosexual men in the Los Angeles area. Rasheed S, Norman GL, Gill PS, Meyer PR, Cheng L, Levine AM. Virology; 1986 Apr 15; 150(1):1-9. PubMed ID: 3006329 [Abstract] [Full Text] [Related]
17. Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome. Sundqvist VA, Linde A, Kurth R, Werner A, Helm EB, Popovic M, Gallo RC, Wahren B. J Infect Dis; 1986 May 15; 153(5):970-3. PubMed ID: 3009638 [No Abstract] [Full Text] [Related]
18. Serum beta-2 microglobulin levels in homosexual men with AIDS and with persistent, generalized lymphadenopathy. Burkes RL, Sherrod AE, Stewart ML, Gill PS, Aguilar S, Taylor CR, Krailo MD, Levine AM. Cancer; 1986 Jun 01; 57(11):2190-2. PubMed ID: 3008977 [Abstract] [Full Text] [Related]
19. Antibodies to human T lymphotropic virus type III demonstrated by a dot immunobinding assay. Biberfeld G, Bredberg-Råden U, Böttiger B, Biberfeld P, Morfeldt-Månsson L, Suni J, Vaheri A, Saxinger C, Gallo R. Scand J Immunol; 1985 Mar 01; 21(3):289-92. PubMed ID: 2986278 [Abstract] [Full Text] [Related]
20. Clinical findings and serological evidence of HTLV-III infection in homosexual contacts of patients with AIDS and persistent generalised lymphadenopathy in London. Gazzard BG, Shanson DC, Farthing C, Lawrence AG, Tedder RS, Cheingsong-Popov R, Dalgleish A, Weiss RA. Lancet; 1984 Sep 01; 2(8401):480-3. PubMed ID: 6147547 [Abstract] [Full Text] [Related] Page: [Next] [New Search]